Rutten, G. E. H. M.

Attributes of clinical guidelines that influence use of guidelines in general practice: observational study

Grol, R., Dalhuijsen, J., Thomas, S., Veld, C. I. ‘., Rutten, G., & Mokkink, H. (1998) · BMJ

Clinical practice guidelines implementationHealth Sciences Research and Education

Cited by 877

α-Glucosidase Inhibitors for Patients With Type 2 Diabetes

van de Laar, F. A., Lucassen, P. L., Akkermans, R. P., van de Lisdonk, E. H., Rutten, G. E., & van Weel, C. (2005) · Diabetes Care

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 690

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial

Griffin, S. J., Borch-Johnsen, K., Davies, M. J., Khunti, K., Rutten, G. E., Sandbæk, A., Sharp, S. J., Simmons, R. K., van den Donk, M., Wareham, N. J., et al. (2011) · The Lancet

Health Promotion and Cardiovascular PreventionDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 462

High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes

Boonman-de Winter, L. J. M., Rutten, F. H., Cramer, M. J. M., Landman, M. J., Liem, A. H., Rutten, G. E. H. M., & Hoes, A. W. (2012) · Diabetologia

Cardiovascular Function and Risk FactorsHeart Failure Treatment and Management

Cited by 343

Alpha-glucosidase inhibitors for type 2 diabetes mellitus

Van de Laar, F. A., Lucassen, P. L., Akkermans, R. P., Van de Lisdonk, E. H., Rutten, G. E., & Van Weel, C. (2005) · Cochrane Database of Systematic Reviews

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 335

GUIDE study: double‐blind comparison of once‐daily gliclazide MR and glimepiride in type 2 diabetic patients

Schernthaner, G., Grimaldi, A., Di Mario, U., Drzewoski, J., Kempler, P., Kvapil, M., Novials, A., Rottiers, R., Rutten, G. E. H. M., & Shaw, K. M. (2004) · European Journal of Clinical Investigation

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 271

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes

Sharif, S., Van der Graaf, Y., Cramer, M. J., Kapelle, L. J., de Borst, G. J., Visseren, F. L. J., Westerink, J., the SMART study group, van Petersen, R., Dinther, B. G. F., et al. (2021) · Cardiovascular Diabetology

Adipokines, Inflammation, and Metabolic DiseasesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 198

Psychological interventions for diabetes-related distress in adults with type 2 diabetes mellitus

Chew, B. H., Vos, R. C., Metzendorf, M.-I., Scholten, R. J., & Rutten, G. E. (2017) · Cochrane Database of Systematic Reviews

Diabetes Management and EducationMindfulness and Compassion Interventions

Cited by 138

Beyond good intentions: The role of proactive coping in achieving sustained behavioural change in the context of diabetes management

Thoolen, B. J., Ridder, D. D., Bensing, J., Gorter, K., & Rutten, G. (2009) · Psychology & Health

Diabetes Management and EducationBehavioral Health and Interventions

Cited by 127

Long-term effects of self-management education for patients with Type 2 diabetes taking maximal oral hypoglycaemic therapy: a randomized trial in primary care

Goudswaard, A. N., Stolk, R. P., Zuithoff, N. P. A., De Valk, H. W., & Rutten, G. E. H. M. (2004) · Diabetic Medicine

Diabetes Management and EducationDiabetes Management and Research

Cited by 112

Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial

Griffin, S. J., Rutten, G. E. H. M., Khunti, K., Witte, D. R., Lauritzen, T., Sharp, S. J., Dalsgaard, E.-M., Davies, M. J., Irving, G. J., Vos, R. C., et al. (2019) · The Lancet Diabetes & Endocrinology

Diabetes Treatment and ManagementHealth Promotion and Cardiovascular Prevention

Cited by 55

Implementation of locally adapted guidelines on type 2 diabetes

van Bruggen, R., Gorter, K. J., Stolk, R. P., Verhoeven, R. P., & Rutten, G. E. H. M. (2008) · Family Practice

Clinical practice guidelines implementationHealth Policy Implementation Science

Cited by 55

Effectiveness of diabetes self-management education and support via a smartphone application in insulin-treated patients with type 2 diabetes: results of a randomized controlled trial (TRIGGER study)

Boels, A. M., Vos, R. C., Dijkhorst-Oei, L.-T., & Rutten, G. E. H. M. (2019) · BMJ Open Diabetes Research & Care

Mobile Health and mHealth ApplicationsDiabetes Management and Education

Cited by 50

Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, triglycerides, and apolipoprotein B and cardiovascular risk in patients with manifest arterial disease

van den Berg, M. J., van der Graaf, Y., de Borst, G. J., Kappelle, L. J., Nathoe, H. M., Visseren, F. L. J., van Petersen, R., van Dinther, B. G. F., Algra, A., van der Graaf, Y., et al. (2016) · The American Journal of Cardiology

Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 39

Personalised treatment targets in type 2 diabetes patients: The Dutch approach

Boels, A. M., Hart, H. E., Rutten, G. E., & Vos, R. C. (2017) · Primary Care Diabetes

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 20